SCHEMBL22940968

SCHEMBL22940968

Cn1ccc(-c2cccnc2O)n1

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CASP6 P55212 1/20 0.49
KMT2A Q03164 1/20 0.44
JMJD6 Q6NYC1 7/20 0.41
NTRK1 P04629 2/20 0.40
ADRA1D P25100 1/20 0.39
ADRA1A P35348 1/20 0.39
ADRA1B P35368 1/20 0.39
TGFBR1 P36897 1/20 0.39
KEAP1 Q14145 1/20 0.38
ROCK2 O75116 1/20 0.35
ROCK1 Q13464 1/20 0.35
CDC42BPB Q9Y5S2 1/20 0.35
CYP19A1 P11511 1/20 0.35
LRRK2 Q5S007 1/20 0.35
PIM1 P11309 1/20 0.35
ADORA2A P29274 1/20 0.34
KDM4E B2RXH2 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15885475 0.80 CASP6 (0.47) CASP6KMT2AJMJD6NTRK1ADRA1D
SCHEMBL19480883 0.79 KEAP1 (0.46) CASP6KMT2AJMJD6NTRK1ADRA1D
SCHEMBL1850624 0.79 KMT2A (0.44) CASP6KMT2AJMJD6NTRK1ADRA1D
SCHEMBL1095492 0.77 KMT2A (0.55) CASP6KMT2AADRA1DADRA1AADRA1B
SCHEMBL22940967 0.76 RAB9A (0.47) CASP6KMT2AJMJD6KDM4E
Hydrochloric Acid SCHEMBL30549511 0.76 KMT2A (0.53) CASP6KMT2AADRA1DADRA1AADRA1B
SCHEMBL2592408 0.73 TDP1 (0.44) KMT2AADRA1AKDM4E
SCHEMBL17812984 0.72 KMT2A (0.54) CASP6KMT2AJMJD6NTRK1KEAP1
SCHEMBL6312157 0.71 KMT2A (0.44) CASP6KMT2AJMJD6ADRA1DADRA1A
SCHEMBL11886366 0.71 KDM4E (0.54) CASP6KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11584745-B2 Aromatic heterocyclic compound, intermediate thereof, preparation method therefor, and pharmaceutical composition and use thereof SHANGHAI YINGLI PHARMACEUTICAL CO., LTD (CN) 2023-02-21 US disclosed
US-20210032241-A1 AROMATIC HETEROCYCLIC COMPOUND, INTERMEDIATE THEREOF, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION AND USE THEREOF SHANGHAI YINGLI PHARMACEUTICAL CO., LTD (CN) 2021-02-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210032241-A1 AROMATIC HETEROCYCLIC COMPOUND, INTERMEDIATE THEREOF, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION AND USE THEREOF ALK, NOTUM, WEE1 CASP6 2844/4885KMT2A 2636/4885JMJD6 2610/4885
US-11584745-B2 Aromatic heterocyclic compound, intermediate thereof, preparation method therefor, and pharmaceutical composition and use thereof ALK, NOTUM, WEE1 CASP6 2844/4885KMT2A 2636/4885JMJD6 2610/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.